NPI Details
Mythily Meda, M.D. is an internal medicine in Chelmsford, MA with 29 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Mythily Meda, M.D. NPI is 1649469925. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
228 BILLERICA RD
CHELMSFORD, MA
ZIP 01824-604
Phone: (978) 250-6000
Fax: (978) 250-6137
The NPI 1649469925 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Hemoglobin a1c level (HCPCS:83036)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Blood creatinine level (HCPCS:82565)
- Blood test, clotting time (HCPCS:85610)
- Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Liver enzyme (sgpt), level (HCPCS:84460)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Urine microalbumin (protein) level (HCPCS:82043)
- Vitamin d-3 level (HCPCS:82306)
- Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) (HCPCS:80051)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Blood potassium level (HCPCS:84132)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Parathormone (parathyroid hormone) level (HCPCS:83970)
- Calcium level, total (HCPCS:82310)
- Iron level (HCPCS:83540)
- Transferrin (iron binding protein) level (HCPCS:84466)
- Automated urinalysis test (HCPCS:81003)
- Phosphate level (HCPCS:84100)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Bacterial colony count, urine (HCPCS:87086)
- Blood sodium level (HCPCS:84295)
- Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Folic acid level, serum (HCPCS:82746)
- Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Albumin (protein) level (HCPCS:82040)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Ferritin (blood protein) level (HCPCS:82728)
- Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- Blood glucose (sugar) level (HCPCS:82947)
- Bacterial culture for aerobic isolates (HCPCS:87077)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Liver function blood test panel (HCPCS:80076)
- Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Uric acid level, blood (HCPCS:84550)
The enumeration date for this NPI number is 10/23/2007 and was last updated on 2/18/2021.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 233659 | MASSACHUSETTS | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 2146894 | MEDICAID | MASSACHUSETTS | |
